Patient Communication Flashcards

A pharmacist is counselling a patient with schizophrenia who has been stabilized on clozapine for two years. The patient's substitute decision-maker (SDM) arrives and insists on being present during all medication counselling sessions. The patient, who currently demonstrates decision-making capacity, quietly tells the pharmacist they do not want their SDM present. What is the pharmacist's most appropriate response?

Answer: Respect the patient's wishes and counsel the patient privately, explaining to the SDM that the patient has capacity and the right to confidentiality

A substitute decision-maker's authority is only activated when the patient lacks decision-making capacity. This patient currently demonstrates capacity, so they retain full autonomy over their healthcare decisions, including who may be present during counselling. The pharmacist must respect the patient's right to privacy and confidentiality, regardless of any pre-existing SDM designation. Allowing the SDM to remain would violate the patient's autonomy and privacy rights under applicable health information legislation.

During a medication review, a First Nations patient declines a pharmacist's offer to demonstrate a new inhaler technique, stating, 'My grandmother taught me the traditional way to breathe for healing and that is what I will follow.' The patient's current inhaler technique appears ineffective based on observed symptom control. Which approach BEST reflects culturally safe pharmacy practice?

Answer: Acknowledge the significance of the traditional practice, explore how both approaches might complement each other, and share clinical concerns about symptom control without dismissing the patient's beliefs

Culturally safe practice requires more than tolerance — it demands active engagement that acknowledges the validity of the patient's worldview while still fulfilling the pharmacist's professional obligation to optimize therapeutic outcomes. Simply deferring (option B) abdicates professional responsibility. Insisting on the biomedical approach (option C) is culturally unsafe. Referring to the physician (option D) avoids the issue. The correct approach opens dialogue, validates the patient's cultural identity, and collaboratively explores how clinical concerns can be addressed without marginalizing their beliefs.

A pharmacist receives a prescription for methotrexate 2.5 mg tablets, with instructions reading 'Take 6 tablets once weekly for rheumatoid arthritis.' While verifying the prescription, the pharmacist notes the directions do not specify a day of the week. Before counselling the patient, what is the MOST clinically critical communication point regarding this medication?

Answer: The patient must take all 6 tablets on the same designated day each week, never on consecutive days, because daily administration causes severe and potentially fatal toxicity

Methotrexate for rheumatoid arthritis (and other non-oncologic indications) is dosed ONCE WEEKLY. This is a known high-alert medication where daily dosing errors have caused patient deaths. The single most critical counselling point is reinforcing that all tablets are taken on the same single day per week and NEVER on consecutive days. While folic acid supplementation (option D) is also important, it is secondary to preventing the life-threatening error of daily administration. Splitting the dose (option C) is not standard practice. Alternating days (option B) is incorrect and dangerous.

A pharmacist is providing telephone counselling to an 82-year-old patient newly started on dabigatran after hospitalization for atrial fibrillation. The patient states, 'I understand everything you said,' but when asked to explain back what to do if they miss a dose, they describe taking a double dose the next day. Using the teach-back method, what is the pharmacist's BEST next step?

Answer: Re-explain the missed dose instructions using simpler language and a different explanation strategy, then ask the patient to teach back again

The teach-back method is used to identify and correct misunderstandings in real time — not to confirm understanding after a single attempt. When the patient's teach-back reveals a misunderstanding (taking a double dose is dangerous with dabigatran and could cause serious bleeding), the pharmacist must immediately re-educate using a different approach, then verify again. Documenting counselling as complete (option B) when a dangerous misconception exists is professionally and ethically unacceptable. A blister pack (option C) does not address the patient's misunderstanding about what to do when a dose is missed. Deferring to family (option D) delays critical safety counselling.

A pharmacist is counselling a patient about starting sertraline for major depressive disorder. The patient asks, 'Will this medication change my personality?' The pharmacist's MOST therapeutically appropriate response is:

Answer: 'Sertraline works by helping to restore chemical imbalances that may be contributing to your depression — many patients describe feeling more like themselves, not different, once it begins working'

This question tests advanced communication skills around medication counselling for psychiatric medications. Option B oversimplifies and dismisses a legitimate concern with a blanket denial. Option C inappropriately deflects a question within the pharmacist's counselling scope. Option D, while partially accurate (emotional blunting is a known SSRI side effect), leads with a negative framing that may increase the patient's anxiety and reduce adherence — it is not the most therapeutically balanced first response. Option A validates the concern, provides a constructive reframe, and invites the patient's engagement without false promises or alarming language, reflecting patient-centred communication principles.

A pharmacist at a community pharmacy receives a call from a nurse at a long-term care facility requesting a verbal medication order for a resident. The nurse states the prescribing physician is unavailable and the resident is experiencing discomfort. The requested medication is acetaminophen 650 mg q4h PRN. Under what circumstance is it appropriate for the pharmacist to act on this verbal order?

Answer: It is never appropriate for a pharmacist to accept a verbal medication order from a nurse — verbal orders must come directly from an authorized prescriber to the pharmacist

Under Canadian pharmacy legislation and standards of practice, pharmacists may only accept verbal orders directly from an authorized prescriber — not relayed through a nurse or other healthcare team member. This protects against transcription errors, miscommunication, and liability issues. Even for a seemingly low-risk medication like acetaminophen, accepting a nurse-relayed verbal order is not appropriate professional practice. The correct action is to contact the prescriber directly to obtain the verbal order or a written/faxed prescription. Option B incorrectly suggests a facility protocol can override legislative requirements. Options C and D inappropriately rationalize dispensing without a valid order.